Pharma in Focus - knowledge in power
IMS
25 - 31 Aug 2008
All pharmaceutical industry jobs

Special Feature: Zuellig to bring Asian model to Australia

The $505 million purchase of Symbion Pharmacy Services by Hong Kong-headquartered pharma distribution business, Zuellig, brings to a close the uncertainty over control of Australia's third major full-line wholesaler. What does the future hold? » more

All pharmaceutical industry jobs
Market Reach
Zest
Reprints Unlimited
Australian Dr
Advertise in Pharma in Focus
News
PBS cost recovery bill defeated

Breaking News- Posted 28 August Government legislation that would impose fees for PBS listing processes on the pharmaceutical industry has been rejected in the Senate by the narrowest of margins  » full report

PBS fees split Senate committee

The Senate Community Affairs Committee has split along party lines in its report on the bill that would introduce fees for PBS listing activities, indicating the final decision will rest with Greens and independent senators  » full report

PBAC: Novartis cheers, not Wyeth

Outcomes from the July meeting of the PBAC, released late last week show Novartis was a big winner but Wyeth lost out  » full report

Pricing authority loses head

The Federal Government is once again searching for someone to chair the Pharmaceutical Benefits Pricing Authority, only 18 months after appointing Dr Michael Nahan to the role  » full report

TGA class action now certain

The race to mount a class action against the TGA on behalf of individuals and business affected by the Pan recall is well and truly under way with a number of plaintiff lawyers said to be chasing the potentially lucrative prize  » full report

Workforce shortage confirmed

Training systems for biopharmaceutical graduates are in line for a huge shake up following new data confirming the industry is facing a significant workforce shortage  » full report

NDPSC acne move opposed

The College of Dermatologists has sworn to oppose a NDPSC attempt to allow GPs to prescribe controversial acne treatment, isotretinoin, best known as Roaccutane  » full report

Bayer takes aim at severe PMS

Bayer Schering Pharma will launch oral contraceptive YAZ in Australia this week with an indication for treatment of premenstrual dysphoric disorder, a severe form of PMS  » full report

Sonic mops up GP network

Pathology company, Sonic Healthcare, is about to achieve its aim of 100% ownership of the country's biggest GP network with over 85 practices and close to 800 GPs under its umbrella  » full report

GSK's Avandia loses key indications

GlaxoSmithKline's diabetes drug, Avandia, the subject of cardiovascular safety concerns over the past 12 months, has lost key indications and PBS funding  » full report

Ascott Sales
SydPath
Archer Emery & Associates
ASMI
Subscribe to Pharma in Focus
People in Pharma
New faces at Nycomed, Agency moves
Nycomed has made two new senior sales and marketing appointments while two medical ad agencies have new bosses
» full report
Your people moves
Nothing interests people in pharma more than what people in pharma are doing and where they're heading. Click here to spread your news
» full report

FREE content
Commercial Services
Comment
Why there won't be an enquiry into the TGA
In the wake of the Pan settlement, the complementary medicines sector on both sides of the Tasman is calling for an enquiry into the Therapeutic Goods Administration but, whatever the merits of the call, an enquiry almost certainly won't happen » full report
Features You May Have Missed
Horizon Scan - Merger activity dominates international landscape
Drug Tracker - Pass rate drops for cost-minimisation submissions
Trial Watch - How economics drive electronic data collection
Market Watch - Antipsychotics - change in a key PBS market
Profile - Meet Jane Orr, MSD's new Aussie MD

FREE content
What's On

© 2007 Lush Media | Privacy Statement | Subscribe to Pharma in Focus | Design: Jolly Good Design